2024 2025 2026 Ivermectin reduces COVID-19 risk: real-time meta-analysis of 106 studies. Significantly lower risk is seen for mortality, ventilation, ICU admission, … A second meta-analysis, Song et al. (2024), reported, “There was no significant difference in all-cause mortality rate between [ivermectin] and controls.” 2024 2025 2025 These findings are in line with a 2024 systematic review and meta-analysis, which found that ivermectin treatment did not reduce the morbidity … 2021 The impact of ivermectin on COVID-19 outcomes: a systematic review and meta-analysis. December 2024; Annals of Medicine and Surgery 87(2). DOI:10.1097/MS9 … 2021 2025 2022 2024 2024 2021 2024 Editor Note to article entitled “Ivermectin for treatment of COVID-19: A systematic review and meta-analysis” [Heliyon 10 (2024) e27647]. Meta-analyses were conducted and certainty of the evidence was assessed using the GRADE approach and additionally in trial sequential analyses … The Medical Research Council (UK) has awarded a £ 3.7 million DPFS grant to expand the work led by the Medicine Quality Research Group on … 2022 2024 Children\’s Health Defense (CHD) is an American 501(c)(3) nonprofit activist group mainly known for anti-vaccine advocacy and is one of the main sources of … Ivermectin meta-analyses highlighted, again, the dangers of fake data · Nature publishes retraction of stem cell studies · More allegations … 2024 CNBC\’s Meg Tirrell reports the National Institutes of Health is looking at alternative drugs to see if they work to fight Covid. The result gathered shows that Ivermectin is effective in treating asymptomatic –to- mild patients only with the collected studies. 2026 2024
